Who owns APREA THERAPEUTICS INC?
- Ticker: APRE
- CUSIP Number: 03836j201
Tip: Access positions for across all investors
Analyze quarterly positions in Aprea Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aprea Therapeutics stock
Who bought or sold APREA THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| AIGH Capital Management | 1.0M | $815k | 0% | Jun 2026 |
|
| Vestal Point Capital | 350k | $281k | 0% | Jun 2026 |
|
| Sphera Funds Management | 270k | $217k | 0% | Jun 2026 |
|
| Nantahala Capital Management | 206k | $165k | 0% | Jun 2026 |
|
| Renaissance Technologies | 106k | $85k | 322% | Jun 2026 |
|
| Geode Capital Management | 75k | $60k | -37% | Jun 2026 |
|
| Citadel Advisors | 59k | $47k | 100% | Jun 2026 |
|
| Bnp Paribas Arbitrage, Snc | 45k | $36k | 14% | Jun 2026 |
|
| Diadema Partners | 45k | $36k | 100% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 39k | $31k | 0% | Jun 2026 |
|
| Susquehanna International | 35k | $28k | 168% | Jun 2026 |
|
| Vanguard Capital Management | 23k | $18k | 17% | Jun 2026 |
|
| Morgan Stanley | 22k | $17k | -71% | Mar 2026 |
|
| LPL Financial | 16k | $13k | -24% | Jun 2026 |
|
| HighTower Advisors | 14k | $11k | 0% | Jun 2026 |
|
| Northern Trust | 14k | $11k | 100% | Jun 2026 |
|
| Persistent Asset Partners | 12k | $9.2k | 100% | Jun 2026 |
|
| XTX Topco | 11k | $8.5k | 100% | Jun 2026 |
|
| BlackRock | 7.2k | $5.8k | -16% | Jun 2026 |
|
| Tower Research Capital | 3.6k | $2.9k | -30% | Jun 2026 |
|
| Group One Trading | 577.00 | $462.984800 | 0% | Jun 2026 |
|
| Barclays | 473.00 | $379.014900 | 100% | Jun 2026 |
|
| Advisor Group Holdings | 295.00 | $236.000000 | 0% | Jun 2026 |
|
| WealthCollab | 158.00 | $127.000400 | 0% | Jun 2026 |
|
| Integrated Wealth Concepts | 46.00 | $35.999600 | 100% | Jun 2026 |
|
| FMR | 45.00 | $36.000000 | 100% | Jun 2026 |
|
| SBI Securities | 16.00 | $13.000000 | 0% | Jun 2026 |
|
| UBS Group | 3.00 | $2.000100 | -100% | Jun 2026 |
|
Who sold out of Aprea Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Scientech Research | Mar 2026 | 60k | $46k |
| Two Sigma Securities | Mar 2026 | 14k | $10k |